Venture Capital

More From Venture Capital

article image

Who Is Winning Continuous Hormone Monitoring And What Comes Next

For decades, a blood draw in a clinical lab was the only way to quantify your hormones. In 2026, that paradigm is shifting and we are seeing saliva cartridges analyzed by smartphone AI, DNA-based biosensor patches, earring-back wearables, and sweat sensors are converging to make hormone tracking as routine as measuring heart rate. The market, valued at $325.7 million in 2025 and projected to reach $716.2 million by 2035, is opening up to a broader hormonal health market representing an estimated $600 billion opportunity The filed is now bubbling up with cohorts of academic breakthroughs, deep tech hardware bets, and AI platforms that are changing how we might be measing hormones in years to come.

ByJosipa Majic Predin,

Contributor

article image

The AI Megacycle: Five Forces Reshaping The Venture Market In 2026

AI’s 2026 megacycle is concentrating capital, compressing startup growth, reshaping IPO and forcing new monetization models that reward durable, AI native advantages.

ByTrueBridge Capital,

Contributor

article image

What It Takes for Investors To Say ‘Yes’

Explore how leading VCs build informed judgment, back non-obvious founders, and design cultures that protect outliers turning ambiguity into long-term impact.

ByKjartan Rist,

Contributor

article image

How Investors Balance Consensus And Conviction

Why the biggest VC wins start with discomfort. Learn how conviction beats consensus in venture capital and why great bets can come from the most unexpected places.

ByKjartan Rist,

Contributor

article image

The Rise And Rise Of AI-Powered Family Offices

How security and governance protocols at family offices are evolving when utilizing "vibe coding" and agentic AI

ByJosipa Majic Predin,

Contributor

article image

The Biological Age Testing Market, From Research Promise To Clinical Reality

The longevity industry has reached an inflection point. With companies like Function Health raising hundreds of millions in venture capital, biological age testing has moved from academic curiosity to investable market category. Yet behind the funding headlines lies a more nuanced reality: a field grappling with fundamental questions about accuracy, stability, and clinical utility.

ByJosipa Majic Predin,

Contributor

article image

Who Owns The AI Hotel Stack? A 2×2 Market Map Of Venture Capital’s Biggest Bets

The money is flowing into hospitality tech at a record pace. But not all AI is created equal. Here is how to read the landscape—and where the real battles are being fought.

ByJosipa Majic Predin,

Contributor

article image

AI Revolution Remaking Hotels, What Is Inside Venture Capital’s Bet On Hospitality’s Future?

As legacy brands scramble to acquire technology startups and asset-light operators crash into bankruptcy, artificial intelligence is redrawing the battle lines in one of the world's oldest industries

ByJosipa Majic Predin,

Contributor

article image

Betting App Novig Raises $75 Million As It Looks To Join Prediction Market Wave

Multiple pivots since the sports gambling firm launched in 2021 have paid off with a $500 million valuation. Now it is chasing federal approval—and industry heavyweights Kalshi and Polymarket.

ByHank Tucker,

Forbes Staff

article image

Legal AI Startup Legora Eyes $400 Million Raise At $5 Billion-Plus Valuation

As investors double down on the promise of automating legal work, the company is in talks to raise $400 million following two rounds in late 2025.

ByIain Martin,

Forbes Staff

article image

As Cancer Strikes Younger Adults, Preventive Screenings Must Evolve

With cancer rising in adults under 50, startups like Prenuvo push whole-body MRI scans for healthy individuals. Can preventive diagnostics catch disease earlier?

ByShimite Obialo,

Contributor

article image

This Startup’s Clever Way To Cut Health Costs Helped It Hit A $1.4 Billion Valuation

Garner Health uses data to identify the country’s best doctors based on quality and cost, then gives its customers’ employees financial incentives to go to them — which can save 12% on healthcare costs.

ByAmy Feldman,

Forbes Staff

article image

Legal AI Startup Harvey In Talks To Raise $200 Million At $11 Billion Valuation

The startup, which develops AI software for lawyers and big law firms, is raising additional capital, increasing its valuation from $8 billion just two months ago.

ByIain Martin,

Forbes Staff

article image

Why VCs Are Going Back To School To Master Human-In-The-Loop AI Systems

As artificial intelligence continues to reshape industries at an unprecedented pace, venture capitalists face a critical knowledge gap: understanding how humans and AI systems collaborate most effectively. While most VCs have mastered the financial and technical aspects of AI investments, few possess deep expertise in behavioral-affective computing; the science of how machines recognize, interpret, and respond to human emotions, or human-in-the-loop (HITL) systems that balance automation with human oversight.

ByJosipa Majic Predin,

Contributor

article image

The Uncomfortable Truth About FDEs

FDEs helps AI companies win enterprise deals fast, but they can also destroy margins and roadmaps. Here’s the real economics behind forward deployment.

ByRocio Wu,

Contributor

article image

Inside Jeffrey Epstein’s Secretive Silicon Valley Investments

Thanks to his relationships to tech billionaires like Peter Thiel and Elon Musk, Epstein had access to a number of lucrative tech investments. But he walked away from several deals with major startups that could have netted him hundreds of millions, the new cache of DOJ emails show.

ByIain Martin,

Forbes Staff

article image

A Former Russian Jewelry Magnate’s Humanoid Robot Startup Is In Talks To Raise $200 Million

Artem Sokolov is in talks with investors to raise a big Series A round for his London-based robotics startup.

ByIain Martin,

Forbes Staff

article image

YC’s 2026 Roadmap Signals A Shift From Human-Augmented To AI-Native Startups

Y Combinator has released its Spring 2026 Request for Startups, with a clear message: artificial intelligence has moved beyond transforming software. Six of the seven highlighted opportunities center on AI systems that actively replace humans rather than assist them. This may be venture capital's clearest signal yet that the industry is betting on automation over augmentation.

ByJosipa Majic Predin,

Contributor

article image

How Jeffrey Epstein Helped His Publicist Become A Big-Time Venture Capitalist

Masha Bucher is one of the more high profile female VCs in Silicon Valley. New emails released from the Department of Justice reveal a deep, years long relationship with convicted sex trafficker Jeffrey Epstein.

ByIain Martin,

Forbes Staff

article image

Conditions At ICE Detention Centers Could Fuel Major Measles Outbreaks

In this week’s edition of InnovationRx, we look at we look at Reed Jobs’ cancer-focused VC fund, Midi Health’s latest fundraise at $1 billion-plus valuation, and more.

ByAmy Feldman,

Forbes Staff